281 related articles for article (PubMed ID: 26745873)
1. Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
Popescu V; Schoonheim MM; Versteeg A; Chaturvedi N; Jonker M; Xavier de Menezes R; Gallindo Garre F; Uitdehaag BM; Barkhof F; Vrenken H
PLoS One; 2016; 11(1):e0143942. PubMed ID: 26745873
[TBL] [Abstract][Full Text] [Related]
2. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
[TBL] [Abstract][Full Text] [Related]
3. Disparate voxel based morphometry (VBM) results between SPM and FSL softwares in ALS patients with frontotemporal dementia: which VBM results to consider?
Rajagopalan V; Pioro EP
BMC Neurol; 2015 Mar; 15():32. PubMed ID: 25879588
[TBL] [Abstract][Full Text] [Related]
4. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
Chu R; Kim G; Tauhid S; Khalid F; Healy BC; Bakshi R
PLoS One; 2018; 13(11):e0206939. PubMed ID: 30408094
[TBL] [Abstract][Full Text] [Related]
5. Repeatability and reproducibility of FreeSurfer, FSL-SIENAX and SPM brain volumetric measurements and the effect of lesion filling in multiple sclerosis.
Guo C; Ferreira D; Fink K; Westman E; Granberg T
Eur Radiol; 2019 Mar; 29(3):1355-1364. PubMed ID: 30242503
[TBL] [Abstract][Full Text] [Related]
6. Methods for Brain Atrophy MR Quantification in Multiple Sclerosis: Application to the Multicenter INNI Dataset.
Storelli L; Pagani E; Pantano P; Piervincenzi C; Tedeschi G; Gallo A; De Stefano N; Battaglini M; Rocca MA; Filippi M;
J Magn Reson Imaging; 2023 Oct; 58(4):1221-1231. PubMed ID: 36661195
[TBL] [Abstract][Full Text] [Related]
7. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis.
Pravatà E; Rocca MA; Valsasina P; Riccitelli GC; Gobbi C; Comi G; Falini A; Filippi M
Mult Scler; 2017 Dec; 23(14):1864-1874. PubMed ID: 28169581
[TBL] [Abstract][Full Text] [Related]
8. Progressive iron accumulation across multiple sclerosis phenotypes revealed by sparse classification of deep gray matter.
Elkady AM; Cobzas D; Sun H; Blevins G; Wilman AH
J Magn Reson Imaging; 2017 Nov; 46(5):1464-1473. PubMed ID: 28301067
[TBL] [Abstract][Full Text] [Related]
9. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
Nocentini U; Bozzali M; Spanò B; Cercignani M; Serra L; Basile B; Mannu R; Caltagirone C; De Luca J
Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774
[TBL] [Abstract][Full Text] [Related]
10. Subcortical brain segmentation of two dimensional T1-weighted data sets with FMRIB's Integrated Registration and Segmentation Tool (FIRST).
Amann M; Andělová M; Pfister A; Mueller-Lenke N; Traud S; Reinhardt J; Magon S; Bendfeldt K; Kappos L; Radue EW; Stippich C; Sprenger T
Neuroimage Clin; 2015; 7():43-52. PubMed ID: 25610766
[TBL] [Abstract][Full Text] [Related]
11. Postmortem validation of MRI cortical volume measurements in MS.
Popescu V; Klaver R; Versteeg A; Voorn P; Twisk JW; Barkhof F; Geurts JJ; Vrenken H
Hum Brain Mapp; 2016 Jun; 37(6):2223-33. PubMed ID: 26945922
[TBL] [Abstract][Full Text] [Related]
12. Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.
Chu R; Hurwitz S; Tauhid S; Bakshi R
BMC Neurol; 2017 Sep; 17(1):172. PubMed ID: 28874119
[TBL] [Abstract][Full Text] [Related]
13. Detection of Cortical and Deep Gray Matter Lesions in Multiple Sclerosis Using DIR and FLAIR at 3T.
Park CC; Thongkham DW; Sadigh G; Saindane AM; Chu R; Bakshi R; Allen JW; Hu R
J Neuroimaging; 2021 Mar; 31(2):408-414. PubMed ID: 33351983
[TBL] [Abstract][Full Text] [Related]
14. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study.
Duan Y; Liu Y; Liang P; Jia X; Yu C; Qin W; Sun H; Liao Z; Ye J; Li K
Eur J Radiol; 2012 Feb; 81(2):e110-4. PubMed ID: 21316170
[TBL] [Abstract][Full Text] [Related]
15. Comparison of automated brain segmentation using a brain phantom and patients with early Alzheimer's dementia or mild cognitive impairment.
Fellhauer I; Zöllner FG; Schröder J; Degen C; Kong L; Essig M; Thomann PA; Schad LR
Psychiatry Res; 2015 Sep; 233(3):299-305. PubMed ID: 26211622
[TBL] [Abstract][Full Text] [Related]
16. Grey matter atrophy is associated with disability increase in natalizumab-treated patients.
Ciampi E; Pareto D; Sastre-Garriga J; Vidal-Jordana A; Tur C; Río J; Tintoré M; Auger C; Rovira A; Montalban X
Mult Scler; 2017 Apr; 23(4):556-566. PubMed ID: 27354019
[TBL] [Abstract][Full Text] [Related]
17. Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks.
Popescu V; Ran NC; Barkhof F; Chard DT; Wheeler-Kingshott CA; Vrenken H
Neuroimage Clin; 2014; 4():366-73. PubMed ID: 24567908
[TBL] [Abstract][Full Text] [Related]
18. The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis.
Lie IA; Kerklingh E; Wesnes K; van Nederpelt DR; Brouwer I; Torkildsen Ø; Myhr KM; Barkhof F; Bø L; Vrenken H
Eur Radiol; 2022 May; 32(5):3576-3587. PubMed ID: 34978580
[TBL] [Abstract][Full Text] [Related]
19. Subcortical grey matter volumes predict subsequent walking function in early multiple sclerosis.
Nourbakhsh B; Azevedo C; Maghzi AH; Spain R; Pelletier D; Waubant E
J Neurol Sci; 2016 Jul; 366():229-233. PubMed ID: 27288812
[TBL] [Abstract][Full Text] [Related]
20. Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients.
Bergsland N; Zivadinov R; Dwyer MG; Weinstock-Guttman B; Benedict RH
Mult Scler; 2016 Sep; 22(10):1327-36. PubMed ID: 26541795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
